Terns Pharmaceuticals TERN

Annual report 2025
added 03-30-2026

Country	USA
IPO year	2021
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	93.2 M
Market Cap^[1]	$ 4.94 B
EBITDA (LTM)	$ -93.7 M
P/E (LTM)	-49.5
P/S (LTM)	-
EPS (LTM)	-1.07

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.